U.S. AI Drug Repurposing Market Gains Momentum as Pfizer Expands AI-Driven Drug Discovery, with Global Market Rising from USD 1.5 billion in 2026  to USD 8.8 billion by 2036 at a 19.4% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The AI drug repurposing market crossed a valuation of USD 1.3 billion in 2025. Demand is projected to increase from USD 1.5 billion in 2026...